Title : The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial - Prins_2014_Alzheimers.Res.Ther_6_47 |
Author(s) : Prins ND , van der Flier WA , Knol DL , Fox NC , Brashear HR , Nye JS , Barkhof F , Scheltens P |
Ref : Alzheimers Res Ther , 6 :47 , 2014 |
Abstract : |
PubMedSearch : Prins_2014_Alzheimers.Res.Ther_6_47 |
PubMedID: 25478019 |
Title : Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial - Wilkinson_2012_J.Alzheimers.Dis_29_459 |
Author(s) : Wilkinson D , Fox NC , Barkhof F , Phul R , Lemming O , Scheltens P |
Ref : J Alzheimers Dis , 29 :459 , 2012 |
Abstract : |
PubMedSearch : Wilkinson_2012_J.Alzheimers.Dis_29_459 |
PubMedID: 22269160 |
Title : Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study - Ballard_2008_Curr.Med.Res.Opin_24_2561 |
Author(s) : Ballard C , Sauter M , Scheltens P , He Y , Barkhof F , van Straaten EC , van der Flier WM , Hsu C , Wu S , Lane R |
Ref : Curr Med Res Opin , 24 :2561 , 2008 |
Abstract : |
PubMedSearch : Ballard_2008_Curr.Med.Res.Opin_24_2561 |
PubMedID: 18674411 |
Title : Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study - Goekoop_2006_Brain_129_141 |
Author(s) : Goekoop R , Scheltens P , Barkhof F , Rombouts SA |
Ref : Brain , 129 :141 , 2006 |
Abstract : |
PubMedSearch : Goekoop_2006_Brain_129_141 |
PubMedID: 16251213 |
Title : Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease - Rombouts_2002_J.Neurol.Neurosurg.Psychiatry_73_665 |
Author(s) : Rombouts SA , Barkhof F , Van Meel CS , Scheltens P |
Ref : Journal of Neurology Neurosurg Psychiatry , 73 :665 , 2002 |
Abstract : |
PubMedSearch : Rombouts_2002_J.Neurol.Neurosurg.Psychiatry_73_665 |
PubMedID: 12438467 |